| Literature DB >> 29056932 |
Rui Wang1,2, Liping Li1, Yin Huang1, Ting Huang1, Jiayou Tang1, Ting Xie3, Aiying Lei1, Fuguang Luo4, Jian Li5, Yan Huang6, Yunliang Shi6, Dongying Wang2, Ming Chen1, Qiang Mi7, Weiyi Huang6.
Abstract
Streptococcus agalactiae, or Group B Streptococcus (GBS), is a major pathogen causing neonatal sepsis and meningitis, bovine mastitis, and fish meningoencephalitis. CC23, including its namesake ST23, is not only the predominant GBS strain derived from human and cattle, but also can infect a variety of homeothermic and poikilothermic species. However, it has never been characterized in fish. This study aimed to determine the pathogenicity of ST23 GBS to fish and explore the mechanisms causing the difference in the pathogenicity of ST23 GBS based on the genome analysis. Infection of tilapia with 10 human-derived ST23 GBS isolates caused tissue damage and the distribution of pathogens within tissues. The mortality rate of infection was ranged from 76 to 100%, and it was shown that the mortality rate caused by only three human isolates had statistically significant difference compared with fish-derived ST7 strain (P < 0.05), whereas the mortality caused by other seven human isolates did not show significant difference compared with fish-derived ST7 strain. The genome comparison and prophage analysis showed that the major genome difference between virulent and non-virulent ST23 GBS was attributed to the different prophage sequences. The prophage in the P1 region contained about 43% GC and encoded 28-39 proteins, which can mediate the acquisition of YafQ/DinJ structure for GBS by phage recombination. YafQ/DinJ belongs to one of the bacterial toxin-antitoxin (TA) systems and allows cells to cope with stress. The ST23 GBS strains carrying this prophage were not pathogenic to tilapia, but the strains without the prophage or carrying the pophage that had gene mutation or deletion, especially the deletion of YafQ/DinJ structure, were highly pathogenic to tilapia. In conclusion, human ST23 GBS is highly pathogenic to fish, which may be related to the phage recombination.Entities:
Keywords: Group B Streptococcus (GBS); ST23; Streptococcus agalactiae; genomic comparison; pathogenicity; sequence type (ST)
Year: 2017 PMID: 29056932 PMCID: PMC5635047 DOI: 10.3389/fmicb.2017.01933
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1The results of experimental infection of tilapia with human ST23 GBS isolates. Mean represented the average cumulative mortality of three parallel groups. *Indicated significant difference with HN016 infection (P < 0.05).
Figure 2The histopathological changes of tilapia infected with GBS. A1–A5 and B1–B5 showed the histopathological results of brain, liver, spleen, kidney, and gut from tilapia injected with GBS or with PBS, respectively. There was no pathological damage in tissues from tilapia infected with PBS. SG, Streptococcus granules, NDD, Nucleus dissolve and disappear; ICI, Inflammatory cells infiltration; HD, hemosiderin deposition; ECD, epithelial cells desquamation.
Figure 3The phylogenetic analysis and CRISPR structure comparison for 20 different ST23 GBS strains. (A) A Maximum Likelihood phylogenetic tree based on 2,154 single copy orthology clusters of the 20 strains. (B) CRISPR loci comparison. Direct repeat sequence was not included; only RT, ST and spacers were represented. The spacer was numbered, and the same number highlighted with same color indicated that the spacer sequence was the same. H, S, B, and D indicated Human, Seal, Bovine, and Dog, respectively.
The analysis of prophage from GBS strains.
| LZF005 (H/ST23) | 1 | 12.9 Kbinc | 14 | Bacter_Diva_NC_028788(2) | 30.85 |
| LZF008 (H/ST23) | 1 | 12.9 Kbinc | 14 | Bacter_Diva_NC_028788(2) | 30.85 |
| 2 | 11.9 Kbinc | 6 | Bacter_Diva_NC_028788(3) | 38.13 | |
| 3 | 7.70 Kbinc | 10 | Salisa_1_NC_017983(1) | 35.17 | |
| NNA004 (H/ST23) | 1 | 54.1 Kbint | 88 | Strept_20617_NC_023503(13) | 35.23 |
| NNA011 (H/ST23) | 1 | 30.3 Kbque | 31 | Clostr_phiCT453B_NC_029004(9) | 43.71 |
| NNA027 (H/ST23) | 1 | 52.5 Kbint | 79 | Strept_20617_NC_023503(14) | 35.51 |
| 2 | 30.3 Kbque | 31 | Strept_phiARI0923_NC_030946(9) | 43.76 | |
| NNA035 (H/ST23) | 1 | 30.3 Kbque | 31 | Clostr_phiCT453B_NC_029004(9) | 43.72 |
| BSE008 (H/ST23) | 1 | 46.6 Kbint | 74 | Strept_20617_NC_023503(14) | 36.17 |
| 2 | 49.6 Kbint | 80 | Strept_20617_NC_023503(14) | 36.09 | |
| 3 | 30.3 Kbque | 31 | Clostr_phiCT453B_NC_029004(9) | 43.77 | |
| NNB011 (H/ST23) | 1 | 53.4 Kbint | 82 | Strept_20617_NC_023503(15) | 35.41 |
| 2 | 30.3 Kbque | 31 | Clostr_phiCT453B_NC_029004(9) | 43.77 | |
| NND002 (H/ST23) | 1 | 30.3 Kbque | 28 | Clostr_phiCT453B_NC_029004(9) | 43.71 |
| 2 | 45.0 Kbint | 69 | Strept_20617_NC_023503(13) | 36.13 | |
| 3 | 48.1 Kbint | 75 | Strept_20617_NC_023503(13) | 36.06 | |
| NND003 (H/ST23) | 1 | 50.9 Kbint | 82 | Strept_20617_NC_023503(13) | 35.23 |
| 2 | 30.3 Kbque | 31 | Gordon_Nymphadora_NC_031061(9) | 43.71 | |
| 515 (H/ST23) | 1 | 15.8 Kbinc | 34 | Strept_T12_NC_028700(10) | 34.75 |
| 2 | 29.7 Kbint | 37 | Strept_phi3396_NC_009018(9) | 36.05 | |
| NEM316 (H/ST23) | 1 | 10.4 Kbinc | 10 | Strept_9874_NC_031023(2) | 36.78 |
| GB00867 (H/ST23) | 1 | 43.4 Kbint | 57 | Lactob_PLE3_NC_031125(20) | 39.33 |
| HN016 (F/ST7) | 1 | 46.2 Kbque | 31 | Clostr_phiCT453B_NC_029004(9) | 41.56 |
| MRI Z1-199 (S/ST23) | 1 | 49.3 Kbint | 69 | Lactob_PLE3_NC_031125(13) | 36.80 |
| 2 | 34.5 Kbque | 38 | Gordon_Kita_NC_031233(9) | 43.36 | |
| MRI Z1-201 (S/ST23) | 1 | 31.4 Kbque | 35 | Clostr_phiCT453B_NC_029004(9) | 42.98 |
| MRI Z1-200 (S/ST23) | 1 | 34.5 Kbque | 39 | Gordon_Kita_NC_031233(9) | 43.36 |
| 2 | 59.7 Kbint | 71 | Strept_phiARI0131_2_NC_031941(13) | 36.33 | |
| MRI Z1-202 (S/ST23) | 1 | 34.5 Kbque | 39 | Gordon_Kita_NC_031233(9) | 43.35 |
| MRI Z1-203 (S/ST23) | 1 | 34.5 Kbque | 39 | Gordon_Kita_NC_031233(9) | 43.36 |
| 2 | 59.7 Kbint | 71 | Strept_phiARI0131_2_NC_031941(13) | 36.33 | |
| FSL S3-026 (B/ST67) | 1 | 31.2 Kbque | 32 | Clostr_phiCT453B_NC_029004(9) | 43.20 |
| 2 | 48.5 Kbque | 32 | Strept_phiARI0746_NC_031907(10) | 40.89 | |
| 3 | 15.0 Kbinc | 22 | Staphy_SPbeta_like_NC_029119(4) | 35.62 |
.
The phage(s) with the highest number of proteins most similar to those in the region.
Figure 4Comparison of GBS genomes. (A) Anvi'o pangenome visualization of 23 GBS genomes. The outer in red, showed the core genome of GBS, protein clusters shared among all the strains. The outer in green, showed the protein clusters shared among seal- and bovine-derived strains (P1 in B). The genomes were clustered based on the presence/absence pattern of protein clusters. Human Ia ST23 strains were highlighted in brown, seal Ia ST23 strains were highlighted in green, fish strains were highlighted in blue, bovine strain FSL S3-026 was highlighted in turquoise. (B) Comparison of genomes of 11 GBS strains. The H021 genome and the MRI Z1-201 genome were served as the reference respectively, and other genomes were aligned; the alignment and the figure were created by the SEED Viewer; each circle represented a different genome, the strain name was labeled on each circle. The circle correlated to reference genome was not shown; the color bar on the bottom indicated the percentage of protein sequence identity against the reference genome. H, S, B, F, and D indicated human, seal, bovine, fish, and dog, respectively.
Gene function of P1 region and coding sequence alignment.
| 1 | hypothetical protein (173) | 100 | 99.42 | 91.28 | 0 | 0 | 0 |
| 2 | hypothetical protein (181) | 100 | 99.44 | 97.22 | 0 | 0 | 0 |
| 3 | phage encoded DNA polymerase I (657) | 100 | 99.85 | 91.53 | 0 | 0 | 88.14 |
| 4 | Phage protein (188) | 100 | 99.47 | 94.25 | 0 | 0 | 96.55 |
| 5 | Phage protein (374) | 100 | 99.73 | 95.43 | 0 | 0 | 91.42 |
| 6 | hypothetical protein (108) | 100 | 100 | 94.39 | 0 | 0 | 88.79 |
| 7 | hypothetical protein (38) | 100 | 100 | 94.59 | 0 | 0 | 0 |
| 8 | DNA primase, phage associated (780) | 97.82 | 97.69 | 93.32 | 0 | 0 | 76.89 |
| 9 | Phage protein (94) | 100 | 100 | 91.4 | 0 | 0 | 83.87 |
| 10 | DNA helicase, phage-associated (459) | 100 | 100 | 93.67 | 0 | 0 | 91.48 |
| 11 | unknown phage protein (166) | 100 | 99.39 | 91.03 | 0 | 0 | 85.28 |
| 12 | S-adenosylmethionine synthetase (247) | 100 | 99.59 | 93.71 | 44.3 | 44.3 | 93.01 |
| 13 | hypothetical protein (49) | 100 | 0 | 0 | 0 | 0 | 0 |
| 14 | mRNA interferase YafQ (91) | 100 | 100 | 0 | 0 | 0 | 0 |
| 15 | Antitoxin DinJ (binds YafQ toxin) (94) | 100 | 100 | 0 | 0 | 0 | 0 |
| 16 | hypothetical protein (152) | 100 | 100 | 88.08 | 0 | 0 | 86.09 |
| 17 | Adenine-specific methyltransferase (418) | 100 | 99.04 | 94.63 | 0 | 0 | 92.94 |
| 18 | endonuclease of the HNH family (197) | 100 | 100 | 0 | 0 | 0 | 0 |
| 19 | DNA-cytosine methyltransferase (393) | 100 | 100 | 95.66 | 0 | 0 | 94.9 |
| 20 | hypothetical protein (45) | 100 | 0 | 0 | 0 | 0 | 0 |
| 21 | hypothetical protein (84) | 100 | 100 | 53.01 | 0 | 0 | 0 |
| 22 | hypothetical protein (130) | 97.67 | 98.41 | 88.89 | 0 | 0 | 58.59 |
| 23 | Phage terminase, small subunit (158) | 100 | 99.36 | 96.82 | 0 | 0 | 96.63 |
| 24 | Phage terminase, large subunit (521) | 100 | 99.81 | 98.27 | 0 | 20.97 | 97.5 |
| 25 | hypothetical protein (98) | 100 | 100 | 97.94 | 0 | 0 | 0 |
| 26 | hypothetical protein (113) | 100 | 100 | 96.43 | 0 | 0 | 0 |
| 27 | hypothetical protein (68) | 100 | 100 | 95.52 | 0 | 0 | 0 |
| 28 | Phage portal protein (446) | 100 | 100 | 95.67 | 0 | 0 | 97.20 |
| 29 | Prophage Clp protease-like protein (175) | 100 | 100 | 78.53 | 0 | 49.59 | 79.31 |
| 30 | Phage major capsid protein (403) | 100 | 100 | 89.55 | 0 | 0 | 89.55 |
| 31 | unknown phage protein (86) | 100 | 100 | 98.82 | 0 | 0 | 97.65 |
| 32 | hypothetical protein (113) | 100 | 100 | 87.5 | 0 | 0 | 91.07 |
| 33 | prophage pi2 protein 37 (123) | 100 | 98.36 | 95.08 | 0 | 0 | 95.90 |
| 34 | prophage pi2 protein 38 (109) | 100 | 100 | 95.37 | 0 | 0 | 93.52 |
| 35 | Prophage pi2 protein 39 (190) | 100 | 98.94 | 98.41 | 0 | 0 | 96.83 |
| 36 | prophage pi2 protein 40 (140) | 99.28 | 96.40 | 99.28 | 0 | 0 | 97.12 |
| 37 | Phage tail length tape-measure protein (1040) | 100 | 97.40 | 96.82 | 0 | 0 | 96.63 |
| 38 | hypothetical protein (242) | 100 | 96.68 | 96.68 | 0 | 0 | 95.44 |
| 39 | Phage endopeptidase (972) | 100 | 99.04 | 92.28 | 0 | 0 | 94.75 |
| 40 | Phage capsid and scaffold (619) | 100 | 99.19 | 95.47 | 0 | 0 | 95.47 |
| 41 | Holin (135) | 100 | 96.27 | 88.06 | 0 | 0 | 71.64 |
| 42 | Phage-associated cell wall hydrolase (490) | 100 | 95.09 | 95.5 | 0 | 0 | 61.86 |
| 43 | Zinc-finger protein (134) | 100 | 95.49 | 93.98 | 0 | 0 | 0 |
| 44 | hypothetical protein (54) | 100 | 96.23 | 96.23 | 0 | 0 | 0 |
| 45 | Site-specific recombinase (403) | 100 | 98.26 | 96.27 | 0 | 0 | 39.03 |
| 46 | Phage integrase (522) | 100 | 99.42 | 94.24 | 0 | 0 | 48.91 |
Percent identity.